Suppr超能文献

临床试验的远程剂量学审核:需要特定供应商模型将图像转换为剂量。

Remote dosimetric auditing of clinical trials: The need for vendor specific models to convert images to dose.

作者信息

Miri Narges, Vial Philip, Greer Peter B

机构信息

School of Mathematical and Physical Sciences, University of Newcastle, Callaghan, NSW, Australia.

Department of Medical Physics, Liverpool and Macarthur Cancer Therapy Centres, Sydney, Australia.

出版信息

J Appl Clin Med Phys. 2019 Jan;20(1):175-183. doi: 10.1002/acm2.12521. Epub 2018 Dec 31.

Abstract

INTRODUCTION

A previous pilot study has demonstrated the feasibility of a novel image-based approach for remote dosimetric auditing of clinical trials. The approach uses a model to convert in-air acquired intensity modulated radiotherapy (IMRT) images to delivered dose inside a virtual phantom. The model was developed using images from an electronic portal imaging device (EPID) on a Varian linear accelerator. It was tuned using beam profiles and field size factors (FSFs) of a series of square fields measured in water tank. This work investigates the need for vendor specific conversion models for image-based auditing. The EPID measured profile and FSF data for Varian (vendor 1) and Elekta (vendor 2) systems are compared along with the performance of the existing Varian model (VM) and a new Elekta model (EM) for a series of audit IMRT fields measured on vendor 2 systems.

MATERIALS AND METHODS

The EPID measured beam profile and FSF data were studied for the two vendors to quantify and understand their relevant dosimetric differences. Then, an EM was developed converting EPID to dose in the virtual water phantom using a vendor 2 water tank data and images from corresponding EPID. The VM and EM were compared for predicting vendor 2 measured dose in water tank. Then, the performance of the new EM was compared to the VM for auditing of 54 IMRT fields from four vendor 2 facilities. Statistical significance of using vendor specific models was determined.

RESULTS

Observed dosimetry differences between the two vendors suggested developing an EM would be beneficial. The EM performed better than VM for vendor 2 square and IMRT fields. The IMRT audit gamma pass rates were (99.8 ± 0.5)%, (98.6 ± 2.3)% and (97.0 ± 3.0)% at respectively 3%/3 mm, 3%/2 mm and 2%/2 mm with improvements at most fields compared with using the VM. For the pilot audit, the difference between gamma results of the two vendors was reduced when using vendor specific models (VM: P < 0.0001, vendor specific models: P = 0.0025).

CONCLUSION

A new model was derived to convert images from vendor 2 EPIDs to dose for remote auditing vendor 2 deliveries. Using vendor specific models is recommended to remotely audit systems from different vendors, however, the improvements found were not major.

摘要

引言

先前的一项试点研究证明了一种基于图像的新型方法用于临床试验远程剂量学审核的可行性。该方法使用一个模型将空中采集的调强放射治疗(IMRT)图像转换为虚拟体模内的实际剂量。该模型是使用瓦里安直线加速器上的电子射野影像装置(EPID)的图像开发的。它通过在水箱中测量的一系列方形射野的射束剖面和射野尺寸因子(FSF)进行了调整。这项工作研究了基于图像审核是否需要特定厂商的转换模型。将瓦里安(厂商1)和医科达(厂商2)系统的EPID测量的剖面和FSF数据以及现有瓦里安模型(VM)和新的医科达模型(EM)对在厂商2系统上测量的一系列审核IMRT射野的性能进行了比较。

材料与方法

研究了两个厂商的EPID测量的射束剖面和FSF数据,以量化和了解它们相关的剂量学差异。然后,使用厂商2的水箱数据和相应EPID的图像开发了一个将EPID转换为虚拟水体模中剂量的EM。比较了VM和EM在预测水箱中厂商2测量剂量方面的情况。然后,将新EM的性能与VM对来自四个厂商2设施的54个IMRT射野的审核性能进行了比较。确定了使用特定厂商模型的统计学显著性。

结果

观察到的两个厂商之间的剂量学差异表明开发一个EM会是有益的。对于厂商2的方形和IMRT射野,EM的性能优于VM。在分别为3%/3毫米、3%/2毫米和2%/2毫米的情况下,IMRT审核的γ通过率分别为(99.8±0.5)%、(98.6±2.3)%和(97.0±3.0)%,与使用VM相比,大多数射野都有改善。对于试点审核,使用特定厂商模型时两个厂商的γ结果差异减小(VM:P<0.0001,特定厂商模型:P = 0.0025)。

结论

推导了一个新模型,用于将厂商2的EPID图像转换为剂量,以远程审核厂商2的放疗剂量。建议使用特定厂商模型对不同厂商的系统进行远程审核,然而,发现的改进并不显著。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5e6/6333142/f721cfb8cf96/ACM2-20-175-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验